Source: GlobeNewswire

Press Release: Cidara : Cidara Therapeutics to Participate in Antifungal and COVID-19 Therapeutics Panels at Maxim Group's Infectious Disease Virtual Conference

SAN DIEGO, April 28, 2020 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel anti-infectives, today announced that Jeffrey Stein, Ph.D., President and Chief Executive Officer, will participate in two panels discussing antifungal and COVID-19 therapies at the upcoming Infectious Disease Virtual Conference presented by Maxim Group.

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Employees
Jeffrey Stein's photo - President & CEO of Cidara

President & CEO

Jeffrey Stein

CEO Approval Rating

90/100

Cidara develops and commercializes novel anti-infectives and immunotherapies for the treatment of fungal infections. Read more